Bottles of Avandia diabetes medication
Bottles of Avandia diabetes medication - 
Listen To The Story
Marketplace

TEXT OF STORY

Doug Krizner: GlaxoSmithKline's second-biggest selling drug, Avandia, is in trouble again. German researchers say the diabetes medication doesn't work, and it could even be harmful. Stephen Beard reports.


Stephen Beard: The German research is pretty damning.

Dr. Bernd Richter of Heinrich Heine University in Dusseldorf found no evidence that Avandia brought any benefit to diabetes patients.

On the other hand, he said, there was plenty of evidence of negative side effects, including weight gain and bone fractures and, more worryingly, an increased risk of heart attack.

Dr. Bernd Richter: We found what is called oedema, that is swelling in the ankles and the lower limbs which could be the first step towards heart failure, was approximately doubled.

His findings are a fresh embarrassment for Glaxo.

A U.S. researcher came to similar conclusions about Avandia earlier in May. Analysts then slashed their earnings forecasts and the Glaxo share price slumped. A Glaxo spokesman dismissed the German findings as inconclusive.

In London, this is Stephen Beard for Marketplace.

“I think the best compliment I can give is not to say how much your programs have taught me (a ton), but how much Marketplace has motivated me to go out and teach myself.” – Michael in Arlington, VA

As a nonprofit news organization, what matters to us is the same thing that matters to you: being a source for trustworthy, independent news that makes people smarter about business and the economy. So if Marketplace has helped you understand the economy better, make more informed financial decisions or just encouraged you to think differently, we’re asking you to give a little something back.

Become a Marketplace Investor today – in whatever amount is right for you – and keep public service journalism strong. We’re grateful for your support.